Michele Buck
Analyst · Bernstein. Please proceed with your question.
Okay. Let me do my best on that one to try a great set out. So, C-store is about 15% of our sales. It's declining about 10%. E-commerce is about 2% of our sales and we're seeing the growth rate double there. Now, of course, that's just what we've seen recently. So, all of these are the recent trends. So, of course, I can't predict exactly how that will play forward. Walmart and mass channels and dollar stores, grocery have had pretty good trends as people are really shopping there. They are frequenting those places and also all of those places tend to have or many of them and e-commerce leg that's being leveraged. I'd tell you the other place we are seeing some softness is around drug. So, drug and C-store are the two channels that I think we've seen the biggest softness, plus there were initial huge stock-ups of the initial stock up behavior with huge at clubs, that's moderated a bit. Melissa might have to come back and give you maybe more of the details around the specifics on each piece of trade. But I would say C-store is 15% and drug in that probably 8% range of our total business, and those are the places that are most pressured and then, of course, the rest kind of fall in the middle. If we look at take impulse, take-home and seasonal clearly the softness on impulse is a little bit less than you see in terms of the 10% decline in C-store, because we do still have business coming through, food, drug and mass, so less than that 10%. Take-home obviously driving our growth and seasons we had a really good Easter. So, at this point, what we're gearing up to do is to -- we met our expectations, our sell-in, our net sales shipments, we fell just short on takeaway. So, seasons, I call kind of a wash and then take-home is where we're seeing the strength. But Melissa can give you more details I think offline on that.